Validity and reliability of running gait measurement with the ViMove2 system.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 01 05 2024
accepted: 16 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 31 10 2024
Statut: epublish

Résumé

Running biomechanics have traditionally been analysed in laboratory settings, but this may not reflect natural running gait. Wearable technology has the potential to enable precise monitoring of running gait beyond the laboratory. This study aimed to evaluate the analytical validity and intra-session reliability of temporal running gait outcomes measured by the ViMove2 wearable system in healthy adults. Seventy-four healthy adults (43 males, 31 females, aged 18-55 years) wore the inertial device, ViMove2 on the tibia. Participants ran on a treadmill for one minute at various speeds (8, 10, 12, 14km/hr), completed in a standardised shoe (Saucony Guide Runner). Running gait was measured with the ViMove2 wearable and 3D motion capture (Vicon). Temporal running gait outcomes included ground contact time (GCT) and cadence (steps/min). GCT and cadence from the ViMove2 had face validity with expected changes in outcome with different running speeds, but ViMove2 tended to over-estimate GCT, and under-estimate cadence compared to the reference, especially at slower speeds. GCT demonstrated moderate to good agreement to the reference at speeds >10km/hr, but poor agreement at 8km/hr and within female runners. Cadence had moderate to excellent agreement across speeds compared to the reference. GCT and cadence had excellent reliability across speeds, but at 8km/hr GCT had good agreement between trials. Overall, temporal gait outcomes of GCT and cadence can be measured with the ViMove2, but accuracy and reliability are impacted at slow running speeds and within female runners. Future work is needed to clarify sex or speed-dependent corrections to algorithms / outcomes to aid interpretation and application.

Identifiants

pubmed: 39480797
doi: 10.1371/journal.pone.0312952
pii: PONE-D-24-17273
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0312952

Informations de copyright

Copyright: © 2024 Mason et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Rachel Mason (R)

Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, United Kingdom.

Gillian Barry (G)

Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, United Kingdom.

Gary Hall (G)

Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, United Kingdom.

Alan Godfrey (A)

Department of Computer and Information Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.

Samuel Stuart (S)

Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, United Kingdom.
Department of Neurology, Oregon Health and Science University, Portland, Oregon, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH